Theresa Schweig, Madeleine Fink, Kira Schmidt, Marvin Krawutschke, Saskia Pasche, Eva-Maria Skoda, Martin Teufel, Bernhard W Müller
{"title":"基于正念的干预对肿瘤患者事件相关电位(P3)和抑郁症状的影响","authors":"Theresa Schweig, Madeleine Fink, Kira Schmidt, Marvin Krawutschke, Saskia Pasche, Eva-Maria Skoda, Martin Teufel, Bernhard W Müller","doi":"10.1177/15347354241294057","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> The aim of this study was to investigate changes in P3 amplitude and latency to emotional stimuli with different arousal and valence levels after a mindfulness-based intervention in oncological patients. <b>Methods:</b> P3 amplitude and latency at Fz, Cz, and Pz to emotional salient stimuli differing in valence (positive vs. negative) and arousal (low vs. high) levels were measured in 17 oncological patients (<i>M<sub>age</sub></i> = 51 years, SD = 9.17, females = 11) before and after a mindfulness-based intervention in a waitlist-controlled clinical trial. Group sessions were held 2x/week over a period of 5 weeks. <b>Results:</b> Arousal and valence levels of emotional salient stimuli were significant modulators of P3 amplitudes (<i>P</i> = .050; <i>P</i> = .006, respectively). P3 amplitudes at Fz decreased significantly from pre-waitlist to post-intervention (<i>P</i> = .002). P3 latency for negatively valenced stimuli decreased from pre- to post-intervention with trending significance (<i>P</i> = .080). P3 latency at Pz showed a trend of being shorter than P3 latency at Cz (<i>P</i> = .066). Depressive symptoms showed a decreasing trend from pre- to post-treatment (<i>P</i> = .075). <b>Conclusions:</b> We could show that arousal and valence levels of emotional salient stimuli are important modulators of P3 amplitudes and latencies in oncological patients. P3 amplitudes at Fz decreased significantly from pre-waitlist until after mindfulness-based intervention, decreases from pre-to post-intervention were linear, but not significant. In oncological patients the mindfulness-based intervention seems to have its strongest effect on the frontal electrode Fz, not the electrode Pz where its amplitude was largest. Depressive symptoms could be reduced.</p>","PeriodicalId":13734,"journal":{"name":"Integrative Cancer Therapies","volume":"23 ","pages":"15347354241294057"},"PeriodicalIF":2.9000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11650600/pdf/","citationCount":"0","resultStr":"{\"title\":\"Effects of a Mindfulness-Based Intervention on Event-Related Potentials (P3) and Depressive Symptoms in Oncological Patients.\",\"authors\":\"Theresa Schweig, Madeleine Fink, Kira Schmidt, Marvin Krawutschke, Saskia Pasche, Eva-Maria Skoda, Martin Teufel, Bernhard W Müller\",\"doi\":\"10.1177/15347354241294057\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Objective:</b> The aim of this study was to investigate changes in P3 amplitude and latency to emotional stimuli with different arousal and valence levels after a mindfulness-based intervention in oncological patients. <b>Methods:</b> P3 amplitude and latency at Fz, Cz, and Pz to emotional salient stimuli differing in valence (positive vs. negative) and arousal (low vs. high) levels were measured in 17 oncological patients (<i>M<sub>age</sub></i> = 51 years, SD = 9.17, females = 11) before and after a mindfulness-based intervention in a waitlist-controlled clinical trial. Group sessions were held 2x/week over a period of 5 weeks. <b>Results:</b> Arousal and valence levels of emotional salient stimuli were significant modulators of P3 amplitudes (<i>P</i> = .050; <i>P</i> = .006, respectively). P3 amplitudes at Fz decreased significantly from pre-waitlist to post-intervention (<i>P</i> = .002). P3 latency for negatively valenced stimuli decreased from pre- to post-intervention with trending significance (<i>P</i> = .080). P3 latency at Pz showed a trend of being shorter than P3 latency at Cz (<i>P</i> = .066). Depressive symptoms showed a decreasing trend from pre- to post-treatment (<i>P</i> = .075). <b>Conclusions:</b> We could show that arousal and valence levels of emotional salient stimuli are important modulators of P3 amplitudes and latencies in oncological patients. P3 amplitudes at Fz decreased significantly from pre-waitlist until after mindfulness-based intervention, decreases from pre-to post-intervention were linear, but not significant. In oncological patients the mindfulness-based intervention seems to have its strongest effect on the frontal electrode Fz, not the electrode Pz where its amplitude was largest. Depressive symptoms could be reduced.</p>\",\"PeriodicalId\":13734,\"journal\":{\"name\":\"Integrative Cancer Therapies\",\"volume\":\"23 \",\"pages\":\"15347354241294057\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11650600/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Integrative Cancer Therapies\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/15347354241294057\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"INTEGRATIVE & COMPLEMENTARY MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Integrative Cancer Therapies","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15347354241294057","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
Effects of a Mindfulness-Based Intervention on Event-Related Potentials (P3) and Depressive Symptoms in Oncological Patients.
Objective: The aim of this study was to investigate changes in P3 amplitude and latency to emotional stimuli with different arousal and valence levels after a mindfulness-based intervention in oncological patients. Methods: P3 amplitude and latency at Fz, Cz, and Pz to emotional salient stimuli differing in valence (positive vs. negative) and arousal (low vs. high) levels were measured in 17 oncological patients (Mage = 51 years, SD = 9.17, females = 11) before and after a mindfulness-based intervention in a waitlist-controlled clinical trial. Group sessions were held 2x/week over a period of 5 weeks. Results: Arousal and valence levels of emotional salient stimuli were significant modulators of P3 amplitudes (P = .050; P = .006, respectively). P3 amplitudes at Fz decreased significantly from pre-waitlist to post-intervention (P = .002). P3 latency for negatively valenced stimuli decreased from pre- to post-intervention with trending significance (P = .080). P3 latency at Pz showed a trend of being shorter than P3 latency at Cz (P = .066). Depressive symptoms showed a decreasing trend from pre- to post-treatment (P = .075). Conclusions: We could show that arousal and valence levels of emotional salient stimuli are important modulators of P3 amplitudes and latencies in oncological patients. P3 amplitudes at Fz decreased significantly from pre-waitlist until after mindfulness-based intervention, decreases from pre-to post-intervention were linear, but not significant. In oncological patients the mindfulness-based intervention seems to have its strongest effect on the frontal electrode Fz, not the electrode Pz where its amplitude was largest. Depressive symptoms could be reduced.
期刊介绍:
ICT is the first journal to spearhead and focus on a new and growing movement in cancer treatment. The journal emphasizes scientific understanding of alternative medicine and traditional medicine therapies, and their responsible integration with conventional health care. Integrative care includes therapeutic interventions in diet, lifestyle, exercise, stress care, and nutritional supplements, as well as experimental vaccines, chrono-chemotherapy, and other advanced treatments. Contributors are leading oncologists, researchers, nurses, and health-care professionals.